Related Experiment Video
Updated: Jul 7, 2026
08:30
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
Published on: September 11, 2011
Improving pediatric dosing through pediatric initiatives: what we have learned
William Rodriguez1, Arzu Selen, Debbie Avant
1Food and Drug Administration, 5600 Fisher Lane, Parklawn Building, Room 13B-45, Rockville, MD 20850, USA. william.rodriguez@fda.hhs.gov
Pediatrics
|March 4, 2008
Summary
Pediatric drug studies significantly improved drug labeling, revealing unique dosing needs for children. Standard weight-based calculations are insufficient due to variable drug clearance in pediatric patients.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Drug Development
Background:
- Pediatric drug studies are crucial for optimizing medication use in children.
- Regulatory requirements mandate the submission of pediatric study data.
- Drug labeling requires accurate dosing and safety information for pediatric populations.
Purpose of the Study:
- To evaluate the impact of pediatric drug studies on drug labeling.
- To assess improvements in pediatric dosing information.
- To analyze changes in pharmacokinetic data and safety profiles.
Main Methods:
- Reviewed 108 products with submitted pediatric studies (1998-2005).
- Analyzed changes in drug labeling, focusing on dosing modifications.
- Examined drug clearance as a key factor in pediatric dosing.
Main Results:
- Significant labeling changes included dosing adjustments (23 products), new safety info (34), efficacy concerns (19), new formulations (12), and extended age limits (77).
- 16 specific examples highlighted substantial pharmacokinetic differences in pediatric populations.
- Many products required revisions beyond simple weight-based adult dose calculations.
Conclusions:
- Pediatric drug labeling changes underscore the necessity of unique dosing strategies for children.
- Growth and maturation significantly influence drug pharmacokinetics in pediatric patients.
- Drug clearance variability in children necessitates specialized dosing, not extrapolation from adult data.
Related Concept Videos
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...